Infinium Global Research has
published a new market research report on hormone replacement market. A hormone
replacement therapy is used to balance hormone associated with menopause and
growth hormone deficiency. Menopause symptoms are treated with the use of
estrogen therapy (ET). It helps in reducing disturbed sleep, hot flashes,
sweating, vaginal dryness and other symptoms caused due to changes of
Figure 1: Global Hormone Replacement Therapy Market by Value 2015
The global hormone replacement
therapy market was sized over USD 5.97 billion in 2015. The global hormone
replacement therapy market is projected to grow with a CAGR between 2.0% and
2.5% during 2017-2023. Increasing in incidence of regularly monitored formulations,
technological advancement in drug delivery systems, growing awareness among the
patients, reformulation of permitted drugs are the key factors driving the
growth of global hormone replacement therapy market. Moreover, injectable
hormones needs to be stored in cold conditions to preserve their efficiency,
high cost of hormone replacement therapy treatment, and the side effect caused
by hormonal replacement therapy are the key factors restraining the growth of
this market. Increasing frequencies of hormonal imbalance disorders and rising
geriatric population suffering from these diseases are likely to bring more
opportunities to this market.
The report segments the hormone
replacement therapy market by type, by route of administration and by region.
Market segmentation based on type includes growth hormone replacement therapy,
estrogen replacement therapy and thyroid hormone replacement therapy. Moreover,
estrogen-replacement therapy accounted for the largest market share of 63.9% in
2015. Oral, parenteral and transdermal is sub-segment of route of
Geographic Coverage and Analysis:
The report provides regional
analysis covering geographies such as Americas, Europe, Asia-Pacific, and Rest
of the World. In this section the key trends and market size for each geography
is provided over the period of 2015 – 2023. Americas was the largest market
among the geographies and contributed over 50.9% of the revenue in the world
hormone replacement therapy market in 2015. Moreover, The U.S. was the largest
contributor in terms of revenue in 2015 due to the awareness about the treatment
procedures. Furthermore, Europe market is expected to grow steadily because of
the increased in inactive lifestyles in the region. Asia Pacific is expected to
grow at the highest CAGR over the forecast period due to increase in demand for
hormone replacement therapies in countries such as Japan, Australia and China.
ROW region is expected to grow gradually over the forecast period.
The companies covered in the
report include Amgen, Genentech, Novo Nordisk, Wyeth, Bayer, MED-EL, Eli Lily,
Merck & Co., Mylan Laboratories, Pfizer and others.
The report provides deep insights
on demand forecasts, market trends and micro and macro indicators. In addition,
this report provides insights on the factors that are driving and restraining
the demand of hormone replacement therapy globally as well as regionally.
Moreover, IGR-Growth Matrix analysis given in the report brings an insight on
the investment areas that existing or new market players can consider. The
report provides insights into the market using analytical tools such as
Porter’s five forces analysis and DRO analysis of hormone replacement therapy.
Moreover, the study highlights
current market trends and provides forecast from 2017 to 2023. We also have
highlighted future trends in the hormone replacement therapy market that will
impact the demand during the forecast period. Moreover, the competitive
analysis given in each regional market brings an insight on the market
strategies of the leading players. This report will help manufacturers,
suppliers and distributors of the hormone replacement therapy market to
understand the present and future trends in this market and formulate their